Inactive Instrument

Other languages Delcath Systems, Inc. Nasdaq

Equities

US24661P5008

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Delcath Systems Amends Supply, Manufacturing Agreement With Synerx Pharma, Mylan Teoranta for Melphalan Hydrochloride	Apr. 26
Delcath Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
Delcath Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 26
Delcath Systems Names Chief Operating Officer	Mar. 19
Delcath Systems, Inc. Appoints Martha S. Rook as Chief Operating Officer	Mar. 18
Delcath Systems, Inc. Announces Healthcare Setting Locator for HEPZATO? KIT (melphalan/Hepatic Delivery System)	Feb. 22
Delcath Systems, Inc. Announces Executive Changes	Feb. 14
Delcath Systems Receives Permanent J-Code for HEPZATO? (melphalan/Hepatic Delivery System) Effective April 1, 2024	Jan. 31
Delcath Systems Launches Hepzato Kit in US for Treatment of Metastatic Uveal Melanoma	Jan. 16
Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing Hepzato Kit?	Jan. 16
Delcath Systems Insider Bought Shares Worth $148,800, According to a Recent SEC Filing	Nov. 20
Delcath Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Delcath Systems Secures $35 Million Funding Linked to FDA Approval of HEPZATO KIT; Shares Rise	23-09-01
Sentiment Subdued After Downbeat China Data, Pushing US Equity Futures Lower Pre-Bell	23-08-15
Top Premarket Gainers	23-08-15
Delcath Systems Says FDA Approved HEPZATO KIT for Metastatic Uveal Melanoma	23-08-15
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma	23-08-14
Delcath Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Delcath Systems Appoints Vojislav Vukovic as Chief Medical Officer	23-06-20
Delcath Systems, Inc. Appoints Sandra Pennell as Senior Vice President of Finance	23-06-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Delcath Systems, Inc. Nasdaq

Equities

US24661P5008

Other languages

Filters